UroGen Pharma Ltd.
URGN
$9.66
-$0.01-0.10%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -5.16% | 3.52% | 46.96% | 19.77% | -7.09% |
| Total Receivables | -10.96% | 30.93% | 23.00% | -8.32% | 20.21% |
| Inventory | 21.50% | 2.04% | 2.75% | 27.67% | 13.41% |
| Prepaid Expenses | -37.06% | 15.11% | 16.37% | 2.04% | -35.90% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.28% | 30.06% | 0.24% | 0.24% | 0.49% |
| Total Current Assets | -6.43% | 5.78% | 41.78% | 16.30% | -7.10% |
|
|
|||||
| Total Current Assets | -6.43% | 5.78% | 41.78% | 16.30% | -7.10% |
| Net Property, Plant & Equipment | 128.25% | -9.29% | -8.91% | -14.87% | -13.49% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 40.37% | -35.73% | -35.95% | -41.49% | -0.53% |
| Total Assets | -5.38% | 7.13% | 40.52% | 12.49% | -7.91% |
|
|
|||||
| Total Accounts Payable | 96.74% | -33.20% | 32.88% | -3.91% | 61.20% |
| Total Accrued Expenses | 16.89% | 3.91% | 31.99% | -18.97% | 14.53% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 85.45% | 3.64% | 2.18% | -4.88% | -4.55% |
| Total Finance Division Other Current Liabilities | 97.60% | 15.01% | 16.79% | -20.49% | 12.84% |
| Total Other Current Liabilities | 97.60% | 15.01% | 16.79% | -20.49% | 12.84% |
| Total Current Liabilities | 40.14% | -4.20% | 29.93% | -15.61% | 21.03% |
|
|
|||||
| Total Current Liabilities | 40.14% | -4.20% | 29.93% | -15.61% | 21.03% |
| Long-Term Debt | 0.02% | 24.43% | 0.23% | -0.98% | 0.03% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 679.72% | -50.12% | -33.28% | -24.53% | -17.74% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.84% | 2.22% | 2.53% | 2.86% | 2.38% |
| Total Liabilities | 6.54% | 9.90% | 4.50% | -1.16% | 3.35% |
|
|
|||||
| Common Stock & APIC | 0.42% | 2.40% | 15.46% | 9.35% | 0.43% |
| Retained Earnings | -4.88% | -3.18% | -4.69% | -4.75% | -3.98% |
| Treasury Stock & Other | -76.27% | 861.29% | 16.22% | -408.33% | 108.96% |
| Total Common Equity | -134.50% | -15.83% | 175.53% | 38.46% | -55.29% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -134.50% | -15.83% | 175.53% | 38.46% | -55.29% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -134.50% | -15.83% | 175.53% | 38.46% | -55.29% |
|
|
|||||